NO20034434D0 - Indolinoner substituert i 6-stilling og deres anvendelse som kinase-inhibitorer - Google Patents
Indolinoner substituert i 6-stilling og deres anvendelse som kinase-inhibitorerInfo
- Publication number
- NO20034434D0 NO20034434D0 NO20034434A NO20034434A NO20034434D0 NO 20034434 D0 NO20034434 D0 NO 20034434D0 NO 20034434 A NO20034434 A NO 20034434A NO 20034434 A NO20034434 A NO 20034434A NO 20034434 D0 NO20034434 D0 NO 20034434D0
- Authority
- NO
- Norway
- Prior art keywords
- kinase inhibitors
- indolinones
- substituted
- indolinones substituted
- kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10117204A DE10117204A1 (de) | 2001-04-06 | 2001-04-06 | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP2002/003583 WO2002081445A1 (de) | 2001-04-06 | 2002-03-30 | In 6-stellung substituierte indoline und ihre verwendung als kinase-inhibitoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20034434D0 true NO20034434D0 (no) | 2003-10-03 |
| NO20034434L NO20034434L (no) | 2003-10-03 |
Family
ID=7680648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20034434A NO20034434L (no) | 2001-04-06 | 2003-10-03 | Indolinoner substituert i 6-stilling og deres anvendelse som kinase-inhibitorer |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6858641B2 (hu) |
| EP (1) | EP1379501A1 (hu) |
| JP (1) | JP2004525173A (hu) |
| KR (1) | KR20030090712A (hu) |
| CN (1) | CN1509270A (hu) |
| AR (1) | AR035813A1 (hu) |
| BG (1) | BG108220A (hu) |
| BR (1) | BR0208900A (hu) |
| CA (1) | CA2442695A1 (hu) |
| CZ (1) | CZ20032975A3 (hu) |
| DE (1) | DE10117204A1 (hu) |
| EA (1) | EA200301005A1 (hu) |
| EC (1) | ECSP034776A (hu) |
| EE (1) | EE200300491A (hu) |
| HU (1) | HUP0303737A3 (hu) |
| IL (1) | IL158254A0 (hu) |
| MX (1) | MXPA03008896A (hu) |
| NO (1) | NO20034434L (hu) |
| PE (1) | PE20021058A1 (hu) |
| PL (1) | PL366458A1 (hu) |
| SK (1) | SK12412003A3 (hu) |
| WO (1) | WO2002081445A1 (hu) |
| ZA (1) | ZA200307306B (hu) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10233500A1 (de) * | 2002-07-24 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel |
| US7148249B2 (en) * | 2002-09-12 | 2006-12-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments |
| JP4879492B2 (ja) * | 2002-11-27 | 2012-02-22 | アラーガン、インコーポレイテッド | 疾患の治療のためのキナーゼ阻害剤 |
| US20060154939A1 (en) * | 2004-12-24 | 2006-07-13 | Boehringer Ingelheim International Gmbh | Medicaments for the Treatment or Prevention of Fibrotic Diseases |
| PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| PE20061155A1 (es) * | 2004-12-24 | 2006-12-16 | Boehringer Ingelheim Int | Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas |
| WO2007057397A1 (en) * | 2005-11-15 | 2007-05-24 | Boehringer Ingelheim International Gmbh | Treatment of cancer |
| ATE510827T1 (de) | 2007-10-12 | 2011-06-15 | Ingenium Pharmaceuticals Gmbh | Inhibitoren von proteinkinasen |
| PE20091445A1 (es) * | 2007-12-03 | 2009-10-19 | Boehringer Ingelheim Int | Derivados de indolinona y procedimiento para su fabricacion |
| US20170065529A1 (en) | 2015-09-09 | 2017-03-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical dosage form for immediate release of an indolinone derivative |
| US8344018B2 (en) * | 2008-07-14 | 2013-01-01 | Gilead Sciences, Inc. | Oxindolyl inhibitor compounds |
| PE20110213A1 (es) | 2008-07-29 | 2011-04-16 | Boehringer Ingelheim Int | Derivados de indolinona como inhibidores de quinasa |
| US8518948B2 (en) | 2010-03-10 | 2013-08-27 | Ingenium Pharmaceuticals Gmbh | Inhibitors of protein kinases |
| CN102267934B (zh) * | 2010-06-02 | 2013-04-17 | 金凯美(大连)医药科技有限公司 | 一种6-甲氧羰基吲哚酮的制备方法 |
| KR20180128390A (ko) | 2015-12-24 | 2018-12-03 | 레스피버트 리미티드 | 인돌리논 화합물과 섬유성 질환의 치료에서 이의 용도 |
| EP3426649B1 (en) | 2016-03-08 | 2020-07-22 | Respivert Limited | Indole derivatives and their use as protein kinase inhibitors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0929520B1 (en) * | 1996-08-23 | 2005-11-02 | Sugen, Inc. | Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
| US6043254A (en) * | 1998-04-03 | 2000-03-28 | Boehringer Ingelheim Pharma Kg | Indolinones having kinase-inhibiting activity |
| DE19816624A1 (de) | 1998-04-15 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US6169106B1 (en) * | 1998-04-15 | 2001-01-02 | Boehringer Ingelheim Pharma Kg | Indolinones having kinase inhibitory activity |
| DE19824922A1 (de) * | 1998-06-04 | 1999-12-09 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US6319918B1 (en) * | 1998-06-04 | 2001-11-20 | Boehringer Ingelheim Pharma Kg | Substituted indolinones with kinase inhibitory activity |
| DE19924401A1 (de) | 1999-05-27 | 2000-11-30 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| DE19940829A1 (de) | 1999-08-27 | 2001-03-01 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| MXPA02002097A (es) | 1999-08-27 | 2002-11-07 | Boehringer Ingelheim Pharma | Indolinas sustituidas como inhibidoras de la tirosina cinasa. |
| DE10042696A1 (de) | 2000-08-31 | 2002-03-14 | Boehringer Ingelheim Pharma | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| UA75054C2 (uk) | 1999-10-13 | 2006-03-15 | Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг | Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу |
-
2001
- 2001-04-06 DE DE10117204A patent/DE10117204A1/de not_active Withdrawn
-
2002
- 2002-03-30 WO PCT/EP2002/003583 patent/WO2002081445A1/de not_active Application Discontinuation
- 2002-03-30 CA CA002442695A patent/CA2442695A1/en not_active Abandoned
- 2002-03-30 BR BR0208900-9A patent/BR0208900A/pt active Pending
- 2002-03-30 PL PL02366458A patent/PL366458A1/xx not_active Application Discontinuation
- 2002-03-30 CZ CZ20032975A patent/CZ20032975A3/cs unknown
- 2002-03-30 IL IL15825402A patent/IL158254A0/xx unknown
- 2002-03-30 JP JP2002579433A patent/JP2004525173A/ja not_active Ceased
- 2002-03-30 SK SK1241-2003A patent/SK12412003A3/sk unknown
- 2002-03-30 HU HU0303737A patent/HUP0303737A3/hu unknown
- 2002-03-30 EE EEP200300491A patent/EE200300491A/xx unknown
- 2002-03-30 EA EA200301005A patent/EA200301005A1/ru unknown
- 2002-03-30 MX MXPA03008896A patent/MXPA03008896A/es unknown
- 2002-03-30 CN CNA028099184A patent/CN1509270A/zh active Pending
- 2002-03-30 EP EP02735201A patent/EP1379501A1/de not_active Withdrawn
- 2002-03-30 KR KR10-2003-7013027A patent/KR20030090712A/ko not_active Application Discontinuation
- 2002-04-04 US US10/116,365 patent/US6858641B2/en not_active Expired - Lifetime
- 2002-04-05 AR ARP020101257A patent/AR035813A1/es not_active Withdrawn
- 2002-04-05 PE PE2002000279A patent/PE20021058A1/es not_active Application Discontinuation
-
2003
- 2003-09-18 ZA ZA200307306A patent/ZA200307306B/xx unknown
- 2003-09-24 EC EC2003004776A patent/ECSP034776A/es unknown
- 2003-10-01 BG BG108220A patent/BG108220A/bg active Pending
- 2003-10-03 NO NO20034434A patent/NO20034434L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0303737A3 (en) | 2004-09-28 |
| CZ20032975A3 (cs) | 2004-02-18 |
| EE200300491A (et) | 2004-02-16 |
| WO2002081445A1 (de) | 2002-10-17 |
| US20030092756A1 (en) | 2003-05-15 |
| KR20030090712A (ko) | 2003-11-28 |
| EP1379501A1 (de) | 2004-01-14 |
| BR0208900A (pt) | 2004-04-20 |
| JP2004525173A (ja) | 2004-08-19 |
| AR035813A1 (es) | 2004-07-14 |
| HUP0303737A2 (hu) | 2004-03-01 |
| DE10117204A1 (de) | 2002-10-10 |
| ZA200307306B (en) | 2004-08-31 |
| ECSP034776A (es) | 2003-12-01 |
| US6858641B2 (en) | 2005-02-22 |
| SK12412003A3 (sk) | 2004-04-06 |
| CN1509270A (zh) | 2004-06-30 |
| BG108220A (bg) | 2004-09-30 |
| PE20021058A1 (es) | 2003-01-20 |
| MXPA03008896A (es) | 2003-12-08 |
| CA2442695A1 (en) | 2002-10-17 |
| EA200301005A1 (ru) | 2004-04-29 |
| IL158254A0 (en) | 2004-05-12 |
| PL366458A1 (en) | 2005-02-07 |
| NO20034434L (no) | 2003-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20026010D0 (no) | Substituerte quinazolinderivater og deres anvendelse som inhibitorer | |
| NO20053356L (no) | Aminindazolderivater og anvendelse derav som kinaseinhibitorer. | |
| DK1480962T3 (da) | 5-Phenylthiazol-derivater og deres anvendelse som P1-3-kinaseinhibitorer | |
| DK1133477T3 (da) | Substituerede benzimidazoler og deres anvendelse som parpinhibitorer | |
| NO20053569D0 (no) | Substituerte 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazinderivater og deres anvendelse som nevrokininantagonister | |
| DK1455785T3 (da) | Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse | |
| NO20021239D0 (no) | Pteridinoner som kinase-inhibitorer | |
| IS6968A (is) | Nýir týrósínkínasa tálmar | |
| DK1317442T3 (da) | Quinolinonderivater som tyrosinkinaseinhibitorer | |
| NO20041887L (no) | Benzomidazoler anvendelige som proteinkinase-inhibitorer | |
| DK1370554T3 (da) | 3-(4-Amidopyrrol-2-ylmethyliden)-2-indolinon-derivater som proteinkinaseinhibitorer | |
| DK3808743T3 (da) | HIV-hæmmende pyrimidin-derivater | |
| NO20034324D0 (no) | Bipiperidinylderivater og deres anvendelse som kjemokin reseptorinhibitor | |
| DK1368349T3 (da) | Xanthinderivater, deres fremstilling og deres anvendelse som lægemidler | |
| ATE505471T1 (de) | Azaindol-kinaseinhibitoren | |
| DK1667991T3 (da) | Quinazolinderivater som tyrosinkinaseinhibitorer | |
| NO20034434D0 (no) | Indolinoner substituert i 6-stilling og deres anvendelse som kinase-inhibitorer | |
| NO20042719L (no) | Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer | |
| NO20043580L (no) | Quinazolinonderivater og deres bruk som CB agonister | |
| DK1387838T3 (da) | Cyanoanthranylamid-derivater og deres anvendelse som lægemidler | |
| NO20053598D0 (no) | Substituerte 1-piperidin-3-yl-4-pyrrolidin-4-yl-piperazinderivater og deres anvendelse som nevrokininantagonister. | |
| DK1562955T3 (da) | Quinazolinderivater som Src-tyrosinkinaseinhibitorer | |
| DK1214302T3 (da) | Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere | |
| NO20043173L (no) | Benzotiazol- og benzoksazol-4,7-dionderivater og deres anvendelse som CDC25-fosfataseinhibitorer | |
| NO20035486D0 (no) | Benzodiazepinderivater og deres anvendelse som AMPA- reseptorstimulatorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |